Several studies have documented the therapeutic efficacy of different NK1R antagonists in rodent models of nociception17,50, and in patients with irritable bowel syndrome, pain and anxiety was reduced by chronic NK1R antagonist treatment51. The gene discussed is TACR1; the disease is Anxiety.